You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API EPHEDRINE SULFATE


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing EPHEDRINE SULFATE

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Nexus Pharamaceuticals Inc EMERPHED ephedrine sulfate 14789-250 SODIUM CHLORIDE
Nexus Pharamaceuticals Inc EMERPHED ephedrine sulfate 14789-250 WATER
Nexus Pharmaceuticals LLC EMERPHED ephedrine sulfate 14789-252 SODIUM CHLORIDE
Nexus Pharmaceuticals LLC EMERPHED ephedrine sulfate 14789-252 WATER
Akorn EPHEDRINE SULFATE ephedrine sulfate 17478-415 ACETIC ACID
Akorn EPHEDRINE SULFATE ephedrine sulfate 17478-415 SODIUM HYDROXIDE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing EPHEDRINE SULFATE

Company Ingredient NDC Excipient
Hikma Pharmaceuticals USA Inc ephedrine sulfate 0641-6238 ACETIC ACID
Hikma Pharmaceuticals USA Inc ephedrine sulfate 0641-6238 SODIUM HYDROXIDE
Hikma Pharmaceuticals USA Inc ephedrine sulfate 0641-6238 WATER
Sandoz Inc ephedrine sulfate 0781-3269 ACETIC ACID
Sandoz Inc ephedrine sulfate 0781-3269 NITROGEN
Sandoz Inc ephedrine sulfate 0781-3269 SODIUM HYDROXIDE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for EPHEDRINE SULFATE

Excipient focus: ACETIC ACID

Excipient focus: NITROGEN

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group